top of page

What should we learn from the COVID pandemic for public

and population health going forward?

Session Leader: Amesh Adalja, Senior Scholar at the Johns Hopkins University Center for Health Security. Dr. Adalja is a global expert on pandemics and their consequences for public health, and population health.


The Forum focused on the lessons of the COVID pandemic, and how C-Suite executives in healthcare and the life sciences should respond.  

  • How will the pandemic affect demand and funding for infectious disease treatment innovation? 

  • Is there a new role for C-Suite leaders in public and population health policies?

  • What may change in relations between industry, the FDA, and approval processes? 

  • How can leaders capture and sustain the improved reputation of healthcare and the life sciences flowing from the vaccine victories? 

  • How is that reputation impacted by the issues around safety and supply?




bottom of page